Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · IEX Real-Time Price · USD
8.06
+0.14 (1.77%)
Apr 22, 2024, 4:00 PM EDT - Market closed

Ironwood Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2007
Cash & Equivalents
92.15657.45621.38364.3178.27174.42125.7462.25270.0382.44
Upgrade
Short-Term Investments
00000095.68251.21178.11174.04
Upgrade
Cash & Cash Equivalents
92.15657.45621.38364.3178.27174.42221.42313.46448.14256.48
Upgrade
Cash Growth
-85.98%5.81%70.57%104.35%2.21%-21.22%-29.36%-30.05%74.73%24.66%
Upgrade
Receivables
129.12130.05138.04145.75149.8480.9582.1664.8554.5225.84
Upgrade
Inventory
00000.6500.741.0804.95
Upgrade
Other Current Assets
12.01-6.87-14.19-14.21-21.9111.067.290.78-2.451.03
Upgrade
Total Current Assets
233.29780.63745.23495.84306.85266.44311.6380.18500.21288.31
Upgrade
Property, Plant & Equipment
18.1720.3122.9325.5130.177.6517.2720.5121.0829.83
Upgrade
Long-Term Investments
00.490.490.490.976.437.06000
Upgrade
Goodwill and Intangibles
3.6800000.79160.69166.900
Upgrade
Other Long-Term Assets
215.93299.1358.2937.4164.7550.75109.06142.2297.8411.19
Upgrade
Total Long-Term Assets
237.79319.89381.763.495.965.62294.08329.64118.9241.02
Upgrade
Total Assets
471.071,1011,127559.24402.75332.05605.67709.82619.12329.32
Upgrade
Accounts Payable
7.830.480.940.665.4914.8915.9617.78.599.76
Upgrade
Deferred Revenue
00000.880008.9916.18
Upgrade
Current Debt
202.693.08121.33.131.1547.634.086.2327.612.41
Upgrade
Other Current Liabilities
65.5921.9639.4628.3833.4257.0145.9967.231.2922.19
Upgrade
Total Current Liabilities
276.125.53161.732.1740.93119.5266.0391.1376.4760.54
Upgrade
Long-Term Debt
512.85412.85355.82462.66454.34400.06488.28479.81429.22160.72
Upgrade
Other Long-Term Liabilities
28.429.773.51.760.738.8441.5272.1618.3119.51
Upgrade
Total Long-Term Liabilities
541.27422.62359.32464.43455.07408.9529.8551.97447.53180.23
Upgrade
Total Liabilities
817.37448.14521.02496.6496528.42595.83643.11524240.77
Upgrade
Total Debt
715.54415.93477.12465.79455.48447.69492.36486.04456.81173.13
Upgrade
Debt Growth
72.03%-12.82%2.43%2.26%1.74%-9.07%1.30%6.40%163.86%-3.25%
Upgrade
Retained Earnings
-1,698.62-696.38-937.61-1,466.06-1,572.23-1,591.13-1,308.76-1,191.82-1,110.12-967.45
Upgrade
Comprehensive Income
-3.0300000-0.08-0.01-0.09-0.02
Upgrade
Shareholders' Equity
-346.3652.38605.9162.64-93.25-196.379.8566.7295.1388.55
Upgrade
Net Cash / Debt
-623.38241.52144.26-101.49-277.21-273.26-270.94-172.58-8.6783.35
Upgrade
Net Cash / Debt Growth
-67.42%-------210.97%
Upgrade
Net Cash Per Share
-4.011.300.88-0.63-1.78-1.79-1.82-1.19-0.060.61
Upgrade
Working Capital
-42.81755.1583.53463.67265.92146.91245.57289.05423.74227.77
Upgrade
Book Value Per Share
-2.234.233.730.39-0.60-1.290.070.460.670.65
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).